Studying the problem of relapses within the central nervous system (CNS) in children with acute lymphoblastic leukaemia (ALL)

ALL is the commonest cancer of childhood and treatment related toxicity and relapse are important therapeutic challenges. To further improve outcome new, non-toxic, targeted therapies need to be developed. These may be targeted to the leukaemic population in general or to the sub-population thought to give rise to relapse. Relapsed disease is characterised by an increased involvement of sites other than the bone marrow. This has led to the suggestion that chemo-resistance and invasion may be linked.

Grant Award – Kidscan PhD Studentship (2012 – 2015)

Funding Award – £65,000.00

Funding Awarded to – Professor Vaskar Saha

Research Location – University of Manchester 

Lead Researcher – Professor Vaskar Saha